Tharimmune, Inc.
USD3.54
+0.22 (+6.63%)
CEO
Mark Wendland
IPO Date
2022-01-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.34
Prev. Close
$3.32
Day Low
$3.32
Day High
$3.58
52W Low
$0.95
52W High
$9.08
Market Cap
$0.14B
Volume
0.36M
| 0 |
| $0.00 |
| 11 Feb 2026 | Wiley William Thomas Jr. | director: | Disposed | 0 | $0.00 |
| 11 Feb 2026 | Asbury Jacob | officer | Disposed | 0 | $0.00 |
| 14 Nov 2025 | Wendland Mark Paul | officer | Disposed | 0 | $0.00 |
| 14 Nov 2025 | Toomey Mark Christopher | officer | Disposed | 0 | $0.00 |
| 5 Nov 2025 | Parikh Sanam | director, officer: COO | A-Award | Acquired | 5,000 | $3.08 |
| 5 Nov 2025 | Liddy James Gordon | director | A-Award | Acquired | 5,000 | $3.08 |
| 5 Nov 2025 | LoPriore Vincent S | director, 10 percent owner, officer: Executive Chairman | A-Award | Acquired | 90,000 | $3.08 |
| 5 Nov 2025 | Rickel Nancy Davis | director | A-Award | Acquired | 5,000 | $3.08 |